134 related articles for article (PubMed ID: 22114948)
1. Molecular mechanisms of glycine transporter GlyT2 mutations in startle disease.
James VM; Gill JL; Topf M; Harvey RJ
Biol Chem; 2012 Apr; 393(4):283-9. PubMed ID: 22114948
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease.
Rees MI; Harvey K; Pearce BR; Chung SK; Duguid IC; Thomas P; Beatty S; Graham GE; Armstrong L; Shiang R; Abbott KJ; Zuberi SM; Stephenson JB; Owen MJ; Tijssen MA; van den Maagdenberg AM; Smart TG; Supplisson S; Harvey RJ
Nat Genet; 2006 Jul; 38(7):801-6. PubMed ID: 16751771
[TBL] [Abstract][Full Text] [Related]
3. Startle disease in Irish wolfhounds associated with a microdeletion in the glycine transporter GlyT2 gene.
Gill JL; Capper D; Vanbellinghen JF; Chung SK; Higgins RJ; Rees MI; Shelton GD; Harvey RJ
Neurobiol Dis; 2011 Jul; 43(1):184-9. PubMed ID: 21420493
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease.
Carta E; Chung SK; James VM; Robinson A; Gill JL; Remy N; Vanbellinghen JF; Drew CJ; Cagdas S; Cameron D; Cowan FM; Del Toro M; Graham GE; Manzur AY; Masri A; Rivera S; Scalais E; Shiang R; Sinclair K; Stuart CA; Tijssen MA; Wise G; Zuberi SM; Harvey K; Pearce BR; Topf M; Thomas RH; Supplisson S; Rees MI; Harvey RJ
J Biol Chem; 2012 Aug; 287(34):28975-85. PubMed ID: 22700964
[TBL] [Abstract][Full Text] [Related]
5. GLRB is the third major gene of effect in hyperekplexia.
Chung SK; Bode A; Cushion TD; Thomas RH; Hunt C; Wood SE; Pickrell WO; Drew CJ; Yamashita S; Shiang R; Leiz S; Longardt AC; Raile V; Weschke B; Puri RD; Verma IC; Harvey RJ; Ratnasinghe DD; Parker M; Rittey C; Masri A; Lingappa L; Howell OW; Vanbellinghen JF; Mullins JG; Lynch JW; Rees MI
Hum Mol Genet; 2013 Mar; 22(5):927-40. PubMed ID: 23184146
[TBL] [Abstract][Full Text] [Related]
6. The glycinergic system in human startle disease: a genetic screening approach.
Davies JS; Chung SK; Thomas RH; Robinson A; Hammond CL; Mullins JG; Carta E; Pearce BR; Harvey K; Harvey RJ; Rees MI
Front Mol Neurosci; 2010; 3():8. PubMed ID: 20407582
[TBL] [Abstract][Full Text] [Related]
7. A novel dominant hyperekplexia mutation Y705C alters trafficking and biochemical properties of the presynaptic glycine transporter GlyT2.
Giménez C; Pérez-Siles G; Martínez-Villarreal J; Arribas-González E; Jiménez E; Núñez E; de Juan-Sanz J; Fernández-Sánchez E; García-Tardón N; Ibáñez I; Romanelli V; Nevado J; James VM; Topf M; Chung SK; Thomas RH; Desviat LR; Aragón C; Zafra F; Rees MI; Lapunzina P; Harvey RJ; López-Corcuera B
J Biol Chem; 2012 Aug; 287(34):28986-9002. PubMed ID: 22753417
[TBL] [Abstract][Full Text] [Related]
8. Mutations within the human GLYT2 (SLC6A5) gene associated with hyperekplexia.
Eulenburg V; Becker K; Gomeza J; Schmitt B; Becker CM; Betz H
Biochem Biophys Res Commun; 2006 Sep; 348(2):400-5. PubMed ID: 16884688
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of the dominant negative effect of a glycine transporter 2 mutation associated with hyperekplexia.
Arribas-González E; de Juan-Sanz J; Aragón C; López-Corcuera B
J Biol Chem; 2015 Jan; 290(4):2150-65. PubMed ID: 25480793
[TBL] [Abstract][Full Text] [Related]
10. Hyperekplexia-associated mutations in the neuronal glycine transporter 2.
López-Corcuera B; Arribas-González E; Aragón C
Neurochem Int; 2019 Feb; 123():95-100. PubMed ID: 29859229
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiological mechanisms of dominant and recessive GLRA1 mutations in hyperekplexia.
Chung SK; Vanbellinghen JF; Mullins JG; Robinson A; Hantke J; Hammond CL; Gilbert DF; Freilinger M; Ryan M; Kruer MC; Masri A; Gurses C; Ferrie C; Harvey K; Shiang R; Christodoulou J; Andermann F; Andermann E; Thomas RH; Harvey RJ; Lynch JW; Rees MI
J Neurosci; 2010 Jul; 30(28):9612-20. PubMed ID: 20631190
[TBL] [Abstract][Full Text] [Related]
12. The genetics of hyperekplexia: more than startle!
Harvey RJ; Topf M; Harvey K; Rees MI
Trends Genet; 2008 Sep; 24(9):439-47. PubMed ID: 18707791
[TBL] [Abstract][Full Text] [Related]
13. Distinct phenotypes in zebrafish models of human startle disease.
Ganser LR; Yan Q; James VM; Kozol R; Topf M; Harvey RJ; Dallman JE
Neurobiol Dis; 2013 Dec; 60():139-51. PubMed ID: 24029548
[TBL] [Abstract][Full Text] [Related]
14. Novel missense mutations in the glycine receptor β subunit gene (GLRB) in startle disease.
James VM; Bode A; Chung SK; Gill JL; Nielsen M; Cowan FM; Vujic M; Thomas RH; Rees MI; Harvey K; Keramidas A; Topf M; Ginjaar I; Lynch JW; Harvey RJ
Neurobiol Dis; 2013 Apr; 52():137-49. PubMed ID: 23238346
[TBL] [Abstract][Full Text] [Related]
15. A critical role for glycine transporters in hyperexcitability disorders.
Harvey RJ; Carta E; Pearce BR; Chung SK; Supplisson S; Rees MI; Harvey K
Front Mol Neurosci; 2008; 1():1. PubMed ID: 18946534
[TBL] [Abstract][Full Text] [Related]
16. Genotype-phenotype correlations in hyperekplexia: apnoeas, learning difficulties and speech delay.
Thomas RH; Chung SK; Wood SE; Cushion TD; Drew CJ; Hammond CL; Vanbellinghen JF; Mullins JG; Rees MI
Brain; 2013 Oct; 136(Pt 10):3085-95. PubMed ID: 24030948
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and genetic analysis of children with hyperekplexia in Korea.
Lee CG; Kwon MJ; Yu HJ; Nam SH; Lee J; Ki CS; Lee M
J Child Neurol; 2013 Jan; 28(1):90-4. PubMed ID: 22532536
[TBL] [Abstract][Full Text] [Related]
18. Rescue of two trafficking-defective variants of the neuronal glycine transporter GlyT2 associated to hyperekplexia.
de la Rocha-Muñoz A; Melgarejo E; Aragón C; López-Corcuera B
Neuropharmacology; 2021 May; 189():108543. PubMed ID: 33794243
[TBL] [Abstract][Full Text] [Related]
19. The glycine transporter GlyT2 controls the dynamics of synaptic vesicle refilling in inhibitory spinal cord neurons.
Rousseau F; Aubrey KR; Supplisson S
J Neurosci; 2008 Sep; 28(39):9755-68. PubMed ID: 18815261
[TBL] [Abstract][Full Text] [Related]
20. Role of the Glycine Receptor β Subunit in Synaptic Localization and Pathogenicity in Severe Startle Disease.
Wiessler AL; Hasenmüller AS; Fuhl I; Mille C; Cortes Campo O; Reinhard N; Schenk J; Heinze KG; Schaefer N; Specht CG; Villmann C
J Neurosci; 2024 Jan; 44(2):. PubMed ID: 37963764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
